Olivia López Arellano (Photo: Cuartoscuro)
At a press conference of the government of the Mexico City, Olivia López Arellano, Secretary of Health, warned about the use of medical treatments that can harm COVID-19 patients.
“We know that there is no specific treatment against el COVID-19, in particular for SARS-COV 2, but there is a set of treatments that not only do not help, but also harm and can aggravate the symptomsYes, ”the secretary mentioned.
These treatments include the uncontrolled use of dexamethasone, which causes a low immunity in people, can replicate the virus, in addition to causing bacterial infections.
He commented that there have been cases of patients who were treated with dexamethasone, which was not indicated since it is only allowed at the hospital level and with the management of specialists.
The official stressed that there are drugs that can only aggravate the disease (PHOTO: ose Luis Gonzalez / REUTERS)
There are other medications such as chlorine dioxide or hydroxychloroquine that only make the picture worse or mask it. “They give him a false feeling that they are being treated and in improvement and when they arrive at the hospital it is already very late”, mentioned the secretary.
“It is very important that this is evaluated by a doctor, in fact in the kiosks, macro-kiosks, health centers, who delivers these medicines and gives the instructions is a doctor from the Ministry of Health”Said López Arellano.
At the same conference, the official explained that ivermectin, which is recommended mainly for the treatment of mild and moderate pneumonia, has contributed to lower viral load and very few negative effects in outpatient and hospital patients.
“29 studies were identified that showed the usefulness of ivermectin in early stages; 12 studies with positive evidence in prophylaxis, 14 studies with evidence as treatment in moderate cases ”, he stressed.
The group of experts to endorse the use of these drugs is made up of staff from the National Institute of Medical Sciences and Nutrition, Salvador Zubiran, the Mexican Institute of Social Security (IMSS), CDMX Health and the Ministry of Education, Science, Technology and Innovation e Mexico City. (Photo: Miguel Sierra / .)
The group of experts to endorse the use of these drugs is made up of staff from the National Institute of Medical Sciences and Nutrition, Salvador Zubirán, the Mexican Institute of Social Security (IMSS), CDMX Health and the Secretariat of Education, Science, Technology and Innovation of Mexico City.
According to a statement from the Coordinating Commission of National Institutes of Health and High Specialty Hospitals, reported that according to the results of a randomized study evaluating treatment against COVID-19, explained dexamethasone should be considered as a pharmacological treatment in hospitalized patients and recommends its use under strict monitoring of infection control.
Studies in Mexico
Currently researchers from National Polytechnic Institute (IPN) have already developed a drug that prevents or hinders the entry of COVID-19 into the human body.
Through a statement, it was reported that specialists are conducting containment and toxicity tests on seven specific compounds of the 20 discovered that could inhibit the interaction of human cells with the virus.
(Photo: Tw / @ IPN_MX)
Doctors Claudia Guadalupe Benítez Cardoza, professor of the Section of Postgraduate Studies and Research (SEPI), of the National School of Medicine and Homeopathy and José Luis Vique Sánchez, graduate of the ENMH and current professor and researcher of the Faculty of Medicine of the Autonomous University of Baja California (UABC), went from validation by web servers to in vitro inhibition tests.
As a result of the above, they identified three compounds with a lot of potential to make an effective drug that prevents the virus from entering cells.
Coronavirus in Mexico: IPN scientists work on a drug that inhibits the entry of COVID-19 into the body
Insabi launched a call to hire health workers in marginalized areas
COVID-19 vaccine in Mexico: this is how UNAM’s ultra-freezers are to conserve Pfizer doses
The active principle to manufacture the Oxford-AstraZeneca vaccine left from Argentina to Mexico